QR Code

Outcomes following the discontinuation of biologic therapy in patients with severe asthma

Background: Biologic therapies are pivotal in managing severe asthma. Despite their efficacy, some patients discontinue biologics, with varying outcomes. Predictors of successful versus unsuccessful discontinuation remain poorly defined. This study aimed to identify clinical factors associated with...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Tadao Nagasaki, Hisako Matsumoto, Takashi Iwanaga, Kazuto Matsunaga, Kiyoshi Sekiya, Tomoya Harada, Shogo Sakurai, Norihiro Harada, Toshiyuki Koya, Koichi Fukunaga, Takeshi Kaneko, Kazuhisa Asai, Yuko Komase, Yasuhiro Gon, Akihiko Tanaka, Hironori Sagara, Hironobu Sunadome, Tatsuya Nagano, Yoichi Nakamura, Akio Niimi, Noboru Hattori, Takashi Hajiro, Hajime Fujimoto, Masayuki Hojo, Nobuaki Miyahara, Masafumi Yamaguchi, Kimiko Tsuji, Akiko Sano, Ryuta Haraguchi, Hiroyuki Sano, Masato Muraki, Yuji Tohda
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2026-07-01
Rangatū:Allergology International
Ngā marau:
Adult asthma
Biologics
Discontinuation
Exacerbation
Severe asthma
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S1323893025001522
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite